AKTX
|
Akari Therapeutics Plc
|
US
|
NASDAQ
|
ARGX
|
argenx SE
|
US
|
NASDAQ
|
GTBP
|
GT Biopharma, Inc.
|
US
|
NASDAQ
|
IMVT
|
Immunovant, Inc.
|
US
|
NASDAQ
|
ARGNF
|
Argen X Nv
|
US
|
OTC
|
UCBJF
|
UCB SA
|
US
|
OTC
|
UCBJY
|
UCB SA
|
US
|
OTC
|
ARGX
|
Argen-X
|
BE
|
BR
|
TUB
|
Tubize-Fin
|
BE
|
BR
|
UCB
|
UCB SA
|
BE
|
BR
|
29A
|
Amphastar P
|
DE
|
F
|
9995
|
Remegen Co Ltd
|
HK
|
HK
|
PUR
|
Pure Biologics Spólka Akcyjna
|
PL
|
WAR
|
1AE
|
Argen-X
|
DE
|
F
|
1AEA
|
argenx SE
|
DE
|
F
|
CN2
|
Catalyst Pharmaceuticals Inc
|
DE
|
F
|
PQB
|
PURE BIOLOGICS ZY -10
|
DE
|
F
|
S1R
|
Shanghai Pharmaceuticals Holding Co. Ltd
|
DE
|
F
|
UNC
|
UCB SA
|
DE
|
F
|
UNC0
|
UCB S.A. UNSP.ADR 1/2
|
DE
|
F
|